newsfilter
← Latest News
PR Newswire·

Intensity Therapeutics, Inc. Announces $2.35 Million Public Offering

Intensity Therapeutics, Inc. (NASDAQ: INTS), ("Intensity" or the "Company") a late-stage clinical biotechnology company focused on the discovery and...